missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
R&D Systems™ Recombinant Human IL-29/IFN-lambda 1 Protein
Klik for at se tilgængelige muligheder
Mængde:
50 μg
Beskrivelse
Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.500-6.00 ng/mL.
Tekniske data
Tekniske data
| Adgangsnummer | Q8IU54.1 |
| Til brug med (applikation) | Bioactivity |
| Formulering | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gen-id (Entrez) | 282618 |
| Molekylvægt (g/mol) | M.W. Observed: 18-22 kDa, under reducing conditions., M.W. Theoretical: 20 kDa |
| Mængde | 50 μg |
| Kilde | E. coli-derived human IL-29/IFN-lambda 1 protein Pro23-Thr200 |
| Opbevaringskrav | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| Endotoksin koncentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Alias | cytokine Zcyto21, IFNL1, IFN-lambda 1, IFN-lambda-1, IL29, IL-29, interferon lambda-1, interferon, lambda 1, interleukin 29 (interferon, lambda 1), interleukin-29, ZCYTO21 |
| Vis mere |
Korrektion af produktindhold
Dit input er vigtigt for os. Udfyld denne formular for at give feedback relateret til indholdet på dette produkt.
Produkttitel
Ser du en mulighed for forbedring?Del en indholdskorrektion